Crossmark Global Holdings Inc. Purchases 6,000 Shares of DaVita Inc. (NYSE:DVA)

Crossmark Global Holdings Inc. boosted its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 19.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,769 shares of the company's stock after buying an additional 6,000 shares during the period. Crossmark Global Holdings Inc.'s holdings in DaVita were worth $5,625,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. UMB Bank n.a. grew its stake in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after buying an additional 76 shares in the last quarter. Copia Wealth Management acquired a new stake in DaVita during the fourth quarter worth about $30,000. SBI Securities Co. Ltd. acquired a new stake in DaVita during the fourth quarter worth about $41,000. Coppell Advisory Solutions LLC lifted its holdings in shares of DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after acquiring an additional 100 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan bought a new position in shares of DaVita in the fourth quarter worth about $55,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Trading Down 0.7%

NYSE DVA traded down $1.03 during trading hours on Friday, reaching $142.43. The company's stock had a trading volume of 537,605 shares, compared to its average volume of 810,558. The firm has a fifty day simple moving average of $140.21 and a 200-day simple moving average of $149.04. The stock has a market cap of $10.75 billion, a P/E ratio of 14.12, a P/E/G ratio of 0.98 and a beta of 1.11. DaVita Inc. has a 52 week low of $131.76 and a 52 week high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. The business had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The firm's quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the business earned $2.26 EPS. Equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DVA has been the subject of a number of research reports. Truist Financial dropped their target price on shares of DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $164.50.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.